Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Ghanshyam Teli, Priyanka Sharma & Pooja A. Chawla. (2023) Exploring the Potential of Substituted 4-Thiazolidinone Derivatives in the Treatment of Breast Cancer: Synthesis, Biological Screening and In Silico Studies. Polycyclic Aromatic Compounds 43:7, pages 6202-6234.
Read now
Read now
Santiago Palacios & María Jesús Cancelo. (2016) Clinical update on the use of ospemifene in the treatment of severe symptomatic vulvar and vaginal atrophy. International Journal of Women's Health 8, pages 617-626.
Read now
Read now
Lin H Soe, Gregory T Wurz, Chiao-Jung Kao & Michael W DeGregorio. (2013) Ospemifene for the treatment of dyspareunia associated with vulvar and vaginal atrophy: potential benefits in bone and breast. International Journal of Women's Health 5, pages 605-611.
Read now
Read now
Rebekah Burich & Michael DeGregorio. (2011) Current treatment options for vulvovaginal atrophy. Expert Review of Obstetrics & Gynecology 6:2, pages 141-151.
Read now
Read now
Luigi Gennari, Daniela Merlotti & Ranuccio Nuti. (2010) Selective estrogen receptor modulator (SERM) for the treatment of osteoporosis in postmenopausal women: focus on lasofoxifene. Clinical Interventions in Aging 5, pages 19-29.
Read now
Read now
Articles from other publishers (23)
Lauren F. Streicher. (2023) Diagnosis, causes, and treatment of dyspareunia in postmenopausal women. Menopause 30:6, pages 635-649.
Crossref
Crossref
Valerie A Flores, Lubna Pal & JoAnn E Manson. (2021) Hormone Therapy in Menopause: Concepts, Controversies, and Approach to Treatment. Endocrine Reviews 42:6, pages 720-752.
Crossref
Crossref
Snehal S. Ashtekar, Neela M. Bhatia & Manish S. Bhatia. (2018) Development of leads targeting ER-α in breast cancer: An in silico exploration from natural domain. Steroids 131, pages 14-22.
Crossref
Crossref
Lauren Streicher & James A. Simon. 2018. Optimizing Breast Cancer Management. Optimizing Breast Cancer Management
167
189
.
Jae Jun ShinSeul Ki KimJung Ryeol LeeChang Suk Suh. (2017) Ospemifene: A Novel Option for the Treatment of Vulvovaginal Atrophy. Journal of Menopausal Medicine 23:2, pages 79.
Crossref
Crossref
P. Antonio. Maldonado, T. Ignacio Montoya, Jesus F. Acevedo, Patrick W. Keller & R. Ann Word. (2017) Effects of vaginal conjugated equine estrogens and ospemifene on the rat vaginal wall and lower urinary tract†. Biology of Reproduction 96:1, pages 81-92.
Crossref
Crossref
Vanessa A. Lukas & James A. Simon. 2017. Essentials of Menopause Management. Essentials of Menopause Management
129
144
.
Natalija Eigeliene, Lauri Kangas, Christina Hellmer, Tommi Kauko, Risto ErkkolaPirkko Härkönen. (2016) Effects of ospemifene, a novel selective estrogen-receptor modulator, on human breast tissue ex vivo. Menopause 23:7, pages 719-730.
Crossref
Crossref
Sebastian Mirkin & James H. Pickar. (2015) Selective estrogen receptor modulators (SERMs): A review of clinical data. Maturitas 80:1, pages 52-57.
Crossref
Crossref
Amber N. McLendon, Valerie B. Clinard & C. Brock Woodis. (2014) Ospemifene for the Treatment of Vulvovaginal Atrophy and Dyspareunia in Postmenopausal Women. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 34:10, pages 1050-1060.
Crossref
Crossref
Barry S. Komm & Sebastian Mirkin. (2014) An overview of current and emerging SERMs. The Journal of Steroid Biochemistry and Molecular Biology 143, pages 207-222.
Crossref
Crossref
Mikko Unkila, Seppo Kari, Emrah Yatkin & Risto Lammintausta. (2013) Vaginal effects of ospemifene in the ovariectomized rat preclinical model of menopause. The Journal of Steroid Biochemistry and Molecular Biology 138, pages 107-115.
Crossref
Crossref
Russell McDaniel & V Jordan. 2013. Early Breast Cancer. Early Breast Cancer
39
49
.
Amarjit Luniwal, Rachael Jetson & Paul Erhardt. 2012. Analogue‐Based Drug Discovery III. Analogue‐Based Drug Discovery III
165
185
.
Peter Vestergaard. (2012) Raloxifene for the treatment of postmenopausal osteoporosis. International Journal of Clinical Rheumatology 7:3, pages 261-269.
Crossref
Crossref
Rebekah A. Burich, Neelima Rakesh Mehta, Gregory T. Wurz, Jamie Lee McCall, Brittany E. Greenberg, Katie E. Bell, Stephen M. Griffey & Michael W. DeGregorio. (2012) Ospemifene and 4-hydroxyospemifene effectively prevent and treat breast cancer in the MTag.Tg transgenic mouse model. Menopause 19:1, pages 96-103.
Crossref
Crossref
Shayne Cox GadGregory T. Wurz & Michael W. DeGregorio. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia.
Srujana Rayalam, Jeong-Yeh Yang, Mary Anne Della-Fera & Clifton A. Baile. (2011) Novel molecular targets for prevention of obesity and osteoporosis. The Journal of Nutritional Biochemistry 22:12, pages 1099-1104.
Crossref
Crossref
James A. Simon. (2011) Identifying and Treating Sexual Dysfunction in Postmenopausal Women: The Role of Estrogen. Journal of Women's Health 20:10, pages 1453-1465.
Crossref
Crossref
Barry S. Komm, Fay Vlasseros, Rana Samadfam, Luc Chouinard & Susan Y. Smith. (2011) Skeletal effects of bazedoxifene paired with conjugated estrogens in ovariectomized rats. Bone 49:3, pages 376-386.
Crossref
Crossref
Clifton A. Baile, Jeong-Yeh Yang, Srujana Rayalam, Diane L. Hartzell, Ching-Yi Lai, Charlotte Andersen & Mary Anne Della-Fera. (2011) Effect of resveratrol on fat mobilization. Annals of the New York Academy of Sciences 1215:1, pages 40-47.
Crossref
Crossref
R C Winneker & H A Harris. (2010) Progress and Prospects in Treating Postmenopausal Vaginal Atrophy. Clinical Pharmacology & Therapeutics 89:1, pages 129-132.
Crossref
Crossref
Fernand Labrie, Céline Martel, Sylvain Gauthier, Georges Pelletier & Jean-Yves Sancéau. (2010) Effect of toremifene and ospemifene, compared to acolbifene, on estrogen-sensitive parameters in rat and human uterine tissues. Hormone Molecular Biology and Clinical Investigation 1:3.
Crossref
Crossref